Sinopharm (company)
Search results
Founded in 1994, Shanghai Fosun Pharmaceutical (Group) Co., Ltd. ("Fosun Pharma"; stock code: 600196. SH, 02196. HK) is a global innovation-driven pharmaceutical and healthcare industry group deep-rooted in China.
Key people. Wu Yifang is the president and CEO of Fosun Pharma. Chen Qiyu is co-CEO of Fosun International and Chairman of Fosun Pharma. History. Fosun Pharmaceutical is a listed company which started A share initial public offering in 1998 and H share in 2012.
- 1994
- pharmaceutical, medical
- Shanghai, China
- Fosun High Technology, Guangxin Technology, and 3 others
People also ask
Who is the CEO of Fosun Pharma?
Is Fosun Pharmaceutical a Chinese company?
What's new at Fosun Pharma USA?
What makes Fosun Pharma a good company?
Rong Yang is the chief executive officer of Fosun Pharma USA and the senior vice president of Fosun Pharma. He is responsible for expanding Fosun Pharma’s presence in the U.S., driving overall business and organizational growth and representing the company in front of external stakeholders.
Fosun Pharma's Executive Director, Chairman and Chief Executive Officer is Wu Yifang. Other executives include Chen Qiyu, Executive Director, Co-CEO of Fosun International; Dong Xiaoxian, Vice President , Secretary of the Board of Directors and Director of the Secretarial Office and 15 others.
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most. Discover our process ». Information on valuation, funding, cap tables, investors, and executives for Fosun Pharma USA. Use the PitchBook Platform to explore the full profile.
- Chief Executive Officer
Mar 22, 2022 · Wu Yifang, Chairman and CEO of Fosun Pharma, said, "Given the pandemic entered a new phase of normalization, Fosun Pharma continued to promote innovation and transformation, as well as the ...
Lily Zou is President and CEO of Fosun Pharma USA, where she is responsible for building and growing Fosun Pharma’s US business. Fosun Pharma USA has R&D, regulatory, and commercialization capabilities, with a portfolio of pharmaceutical and in vitro diagnostic products in the US market. It also invests and incubates cutting-edge technologies ...
